?one prior program of chemotherapy for Highly developed breast cancer and over the entire trial, preceding publicity to any FGFR inhibitor, major medical procedures or radiotherapy within 4 weeks just before 1st dose of review cure and getting strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac conditions precluded pati